LCP Health at ISPOR Europe 2026
Health Health economics outcomes research Market access Real world evidence generation Health equity
The ISPOR Europe 2026 conference, themed “Shaping the Future of Access Through Science and Policy”, will be held on 8-11 November 2026 at the Austria Center Vienna in Vienna, Austria.
LCP Health are delighted to be attending the leading conference for health economics and outcomes research (HEOR). It’s going to be a busy few days, and we would love to connect with you whilst there!
Visit us at Stand 1130 during the conference. We look forward to meeting you!
Join our conference sessions
Short course: Practical Applications of Large Language Models for RWE Generation and HEOR
Dr Ben Bray will be running a short course on practical applications of large language models for real-world evidence generation and HEOR.
Sunday 8 November 2026 | 13.00 – 17.00
Panel: Beyond Healthcare Costs: Valuing Obesity Treatment for Patients, Workforces and Society
Robert King, Senior Health Economist, will be a speaker on this panel, hosted by Novo Nordisk, to discuss the broader value of obesity treatment in HTA settings and beyond.
Tuesday 10 November 2026 | 12.15 – 13.15
Podium presentation: Examining How Health Equity is Considered in Health Technology Assessment: an Analysis of Documents from Four Bodies
Catrin Treharne will be speaking as part of a workshop breaking down five seminal pieces of HTA policy research. Catrin will be presenting research conducted as part of an LCP-lead health equity thought leadership collaboration with three HTA bodies (NICE, CDA-AMC and ICER), and three industry partners (Novo Nordisk, BMS and BeOne).
This research abstract was also recognised as a top 5% finalist.
Wednesday 11 November 2026 | 10.00 – 11.00
Our team will also be presenting 13 posters, four of which have been identified as top 5% finalists
Topics include the transportability of real-world evidence, indirect treatment comparisons, wider societal value, health equity and health technology assessment.
Further details on poster titles and timings of sessions are below:
|
Poster Title |
Poster Session |
|
Reformulating PRO Estimators For Ordinal Outcomes In Oncology |
|
|
TRUST-MM | Translating US Real-World Data to UK Practice: Treatment Patterns and Outcomes in First Line Relapsed/Refractory Multiple Myeloma |
|
|
Quality-Adjusted Life Expectancy (QALE) By Ethnicity In England: Updated Estimates Using The New EQ-5D-5L Value Set. Top 5% finalist |
|
|
National Implementation of the EU HTA regulation: Progress and Approaches across European Countries Top 5% finalist |
|
|
Direct Healthcare Costs for Individuals with Transthyretin Amyloid Cardiomyopathy: Results from a Japanese Electronic Health Record Database |
|
|
Projected Wider Societal and Fiscal Impact of Semaglutide in the United Kingdom |
|
|
Acceptability of Indirect Treatment Comparisons in Orphan Versus Non-Orphan NICE Technology Appraisals |
|
|
Factors Associated with Increased Healthcare Resource Utilisation in Individuals with Transthyretin Amyloid Cardiomyopathy: results from a Japanese Electronic Health Record Database |
|
|
Provisional and Time-limited Access Pathways: A Comparative Analysis of Canada, UK, EU, and Australia |
|
|
Estimating the Fiscal Cost of Stroke in the United Kingdom Top 5% finalist |
|
|
Projected Impact of Semaglutide on Healthcare Resource Utilisation in the United Kingdom |
|
|
Variation in Obesity Burden, Multimorbidity, and Healthcare Costs Across Obesity Class, Sex, and Race/Ethnicity in the United States |
|
|
Healthcare Resource Utilisation for Individuals with Transthyretin Amyloid Cardiomyopathy: Results from a Japanese Electronic Health Record Database |
|
What LCP Health presented at ISPOR Europe 2025
Find out moreSubscribe to our thinking
Get relevant insights, leading perspectives and event invitations delivered right to your inbox. Get started to select your preferences.
